BIOXCEL THERAPEUTICS INC
BTAI·09075P204·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BTAI (BIOXCEL THERAPEUTICS INC) is held by 32 institutional investors as of Q2 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($3M), OAKTREE CAPITAL MANAGEMENT LP ($1.9M), VANGUARD CAPITAL MANAGEMENT LLC ($1.3M). Net institutional sentiment: Bullish.
32
Holders
(2 Elite)
$8.2M
Total Value
81% (21)
Consensus
17 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders May 7, 2026 · Activists Aug 14, 2026 · Congress none
ActivistARArmistice Capital, LLC5.0%Aug 14, 2026
ActivistARArmistice Capital, LLC7.0%May 15, 2026
InsiderRJRodriguez JavierExercise 9K shMay 1, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 33
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer